Skip to main content

Table 1 Study design characteristics of included studies in meta-analysis

From: Comparison of survival benefits of nephron-sparing intervention or active surveillance for patients with localized renal masses: a systematic review and meta-analysis

Study

Year

Region/Country

Study period

Study design

Database

No. of patients

Intervention

Control

Inclusion criteria

Exclusion criteria

Outcome

Quality score

Alam R et al [14]

2018

USA

2009-NA

Prospective cohort

Delayed Intervention and Surveillance for Small Renal Masses Registry

597

PN, TA (CA, RFA)

AS

Age > 18, cT1a renal mass

History of RCC, familial RCC syndrome, or suspicion of a second malignancy metastasis

CSS, OS

9

Miller BL et al [15]

2018

USA

2003–2016

Retrospective

Single center data

135

PN, TA

AS

Histological diagnosis of oncocytoma or chRCC (cT1–2)

NA

CSS, OS

7

Tang DH et al [16]

2017

USA

2000–2013

Retrospective

Single center data

62

PN

AS

Age 80–89, cT1–2 renal mass

NA

CSS, OS

7

Larcher A et al [17]

2015

USA

2000–2009

Retrospective

SEER-Medicare-linked database

1860

TA

AS

T1aN0M0, unilateral RCC

RCC diagnosed only on death

CSS

9

Patel HD et al [18]

2015

USA

1995–2007

Retrospective

SEER-Medicare-linked database

2603

PN

AS

cT1aN0M0 renal cortical tumor

cT3–4, N1–2, M1, unknown classification, urothelial carcinoma, noncortical renal tumors, multiple

procedures, bilateral tumors, previous diagnosis of another

cancer, undergone TA

CSS, OS, CVSS

8

Patel N et al [19]

2012

UK

2005–2010

Retrospective

Cancer Research Uro-Oncology Database

161

PN

AS

cT1aN0M0 renal mass

NA

CSS, OS

7

Lane BR et al [20]

2010

USA

2000–2006

Retrospective

Single center data

391

open/laparoscopic PN, TA (CA, RFA)

AS

Age > 75, cT1 renal tumor

Not suspicious renal tumor, PN for other reason

CSS, OS, CVSS

8

  1. AS active surveillance, CA cryoablation, CSS cancer-specific survival, CVSS cadiovascular-specific survival, NA not available, OS overall survival, PN partial nephrectomy, RCC renal cell carcinoma, RFA radiofrequency ablation, SEER Surveillance, Epidemiology, and End Results, TA thermal ablation